Effects of infused fructose on endogenous glucose production, gluconeogenesis, and glycogen metabolism.
To determine the mechanisms that prevent an increase in gluconeogenesis from increasing hepatic glucose output, six healthy women were infused with [1-13C]fructose (22 mumol.kg-1.min-1), somatostatin, insulin, and glucagon. In control experiment, non-13C-enriched fructose was infused at the same rate without somatostatin, and [U-13C]glucose was infused to measure specifically plasma glucose oxidation. Endogenous glucose production (EGP, [6,6-2H]glucose), net carbohydrate oxidation (CHOox, indirect calorimetry), and fructose oxidation (13CO2) were measured. EGP rate did not increase after fructose infusion with (13.1 +/- 1.2 vs. 12.9 +/- 0.3 mumol.kg-1.min-1) and without (10.3 +/- 0.5 vs. 9.7 +/- 0.5 mumol.kg-1.min-1) somatostatin, despite the fact that gluconeogenesis increased. Nonoxidative fructose disposal, corresponding mainly to glycogen synthesis, was threefold net glycogen deposition, the latter calculated as fructose infusion minus CHOox (14.8 +/- 1.1 and 4.3 +/- 2.0 mumol.kg-1.min-1). It is concluded that 1) the mechanism by which EGP remains constant when gluconeogenesis from fructose increases is independent of changes in insulin and 2) simultaneous breakdown and synthesis of glycogen occurred during fructose infusion.
Institute of Physiology, Faculty of Medicine, University of Lausanne, Switzerland.
P
P
Tounian
P
P
Schneiter
S
S
Henry
E
E
Jéquier
L
L
Tappy
D000328:Adult; D050260:Carbohydrate Metabolism; D004734:Energy Metabolism; D005260:Female; D005632:Fructose / Q000378:metabolism / Q000494:pharmacology*; D005943:Gluconeogenesis / Q000187:drug effects*; D005947:Glucose / Q000096:biosynthesis*; D006003:Glycogen / Q000378:metabolism*; D006728:Hormones / Q000097:blood; D006801:Humans; D007262:Infusions, Intravenous; D010084:Oxidation-Reduction
D006728:Hormones; D005632:Fructose; D006003:Glycogen; D005947:Glucose